T. Cerny
Impact in
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
- Lymphoma Diagnosis and Treatment
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 5
- Lymphoma Diagnosis and Treatment 1
- Oncology 4
- Lung Cancer Research Studies 2
- Co-authors
- N. Thatcher (2 shared papers)H. Anderson (1 shared paper)V Blair (1 shared paper)A Küpfer (3 shared papers)C. Aeschlimann (2 shared papers)M. Tschöp (1 shared paper)K. Kaufmann (1 shared paper)Micha T. Maeder (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Annals of Oncology (2 papers)British Journal of Clinical Pharmacology (1 paper)Biomedical Chromatography (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandUnited KingdomDenmark
In The Last Decade
T. Cerny
15 papers receiving 603 citations
Peers
Comparison fields: 5 of 69
- Endocrine and Autonomic Systems 73
- Pathology and Forensic Medicine 171
- Oncology 262
- Genetics 50
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by T. Cerny
This map shows the geographic impact of T. Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Cerny more than expected).
Fields of papers citing papers by T. Cerny
This network shows the impact of papers produced by T. Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Cerny. The network helps show where T. Cerny may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Cerny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 164 | |
| 2 | 2008 | 128 | |
| 3 | The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). | 2000 | 63 |
| 4 | 1996 | 57 | |
| 5 | 1997 | 47 | |
| 6 | 1998 | 39 | |
| 7 | Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy. | 1998 | 29 |
| 8 | 1987 | 28 | |
| 9 | 1986 | 27 | |
| 10 | 1990 | 21 | |
| 11 | 1999 | 9 | |
| 12 | 2006 | 8 | |
| 13 | 1993 | 5 | |
| 14 | 1991 | 5 | |
| 15 | [Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma]. | 1991 | 3 |
About T. Cerny
T. Cerny is a scholar working on Pathology and Forensic Medicine, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 15 papers that have together received 633 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (5 papers), Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Safe Handling of Antineoplastic Drugs (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (73 citations), Pathology and Forensic Medicine (171 citations), Oncology (262 citations), Genetics (50 citations) and Pulmonary and Respiratory Medicine (123 citations). T. Cerny has collaborated with scholars based in Switzerland, United Kingdom and Denmark. Frequent co-authors include N. Thatcher, H. Anderson, V Blair, A Küpfer, C. Aeschlimann, M. Tschöp, K. Kaufmann, Micha T. Maeder, Birgitte Holst and Roger von Moos. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, British Journal of Clinical Pharmacology, Biomedical Chromatography and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.